Cryptococcosis – Pipeline Review, Pharmaceuticals, Experiments, Research, Analysis, Evolutions H1 2019

Posted on 2019-04-02 by Mark Hub in Healthcare, Pharmaceuticals // 0 Comments

Albany, US, 2019-Apr-02 — /EPR Network/ —This research study added to the broad database of Market Research Hub (MRH) focusing on the Cryptococcosis – Pipeline Review, H1 2019 delivers an in-depth outlook to present information about executive summary and key performance indicators. Furthermore, readers can gather knowledge about the economic status, demographics and competitive landscape which is prevailing in the concerned industry during the review period, 2019. Overall, the purpose of this assessment is to present a clear picture highlighting the transformations expected to occur in the Cryptococcosis driven by major trends and opportunities.

Get Sample Copy of This Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2197330

Cryptococcosis – Pipeline Review, H1 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cryptococcosis – Pipeline Review, H1 2019, provides an overview of the Cryptococcosis (Infectious Disease) pipeline landscape.

Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, head ache, nausea and skin rashes. Predisposing factors are most often seen in people with a weakened immune system, such as those with HIV infection, taking high doses of corticosteroid medications, cancer chemotherapy, or who have Hodgkin’s disease. Treatment includes anti fungal drugs.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Cryptococcosis – Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Cryptococcosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cryptococcosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptococcosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Preclinical and Discovery stages are 1, 5 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.

Cryptococcosis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Cryptococcosis (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Cryptococcosis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Cryptococcosis (Infectious Disease) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Cryptococcosis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Cryptococcosis (Infectious Disease)

BROWSE Full Report NOW @ https://www.marketresearchhub.com/report/cryptococcosis-pipeline-review-h1-2019-report.html

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cryptococcosis – Overview
Cryptococcosis – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cryptococcosis – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cryptococcosis – Companies Involved in Therapeutics Development
Amplyx Pharmaceuticals Inc
Basilea Pharmaceutica Ltd
Novabiotics Ltd
Pulmocide Ltd
Viamet Pharmaceuticals Inc
Visterra Inc
Cryptococcosis – Drug Profiles
APX-001 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Cryptococcosis – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
isavuconazonium sulfate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NP-339 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress

More Information………@@@

Enquire about this Report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2197330

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick